-
-
-
MCH receptor antagonists
-
Patent number 7,132,456
-
Issue date Nov 7, 2006
-
Eli Lilly and Company
-
James Ronald Gillig
-
C07 - ORGANIC CHEMISTRY
-
-
sPLA2 inhibitors
-
Patent number 6,992,100
-
Issue date Jan 31, 2006
-
Eli Lilly and Company
-
Douglas Wade Beight
-
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
-
sPLA2 inhibitors
-
Patent number 6,974,831
-
Issue date Dec 13, 2005
-
Eli Lilly and Company
-
Douglas Wade Beight
-
C07 - ORGANIC CHEMISTRY
-
sPLA2 inhibitors
-
Patent number 6,930,123
-
Issue date Aug 16, 2005
-
Eli Lilly and Company
-
Douglas Wade Beight
-
C07 - ORGANIC CHEMISTRY
-
Spla2 inhibitors
-
Patent number 6,916,840
-
Issue date Jul 12, 2005
-
Eli Lilly and Company
-
Douglas Wade Beight
-
C07 - ORGANIC CHEMISTRY
-
sPLA2 inhibitors
-
Patent number 6,872,743
-
Issue date Mar 29, 2005
-
Eli Lilly and Company
-
Douglas Wade Beight
-
C07 - ORGANIC CHEMISTRY
-
Substituted tricyclics
-
Patent number 6,713,645
-
Issue date Mar 30, 2004
-
Eli Lilly and Company
-
Nicholas James Bach
-
C07 - ORGANIC CHEMISTRY
-
spla2 inhibitors
-
Patent number 6,713,505
-
Issue date Mar 30, 2004
-
Eli Lilly and Company
-
Michael Dean Kinnick
-
C07 - ORGANIC CHEMISTRY
-
-
-
-
Substituted tricyclics
-
Patent number 6,177,440
-
Issue date Jan 23, 2001
-
Eli Lilly and Company
-
Nicholas James Bach
-
C07 - ORGANIC CHEMISTRY
-
-
-
Cell adhesion inhibitors
-
Patent number 6,013,674
-
Issue date Jan 11, 2000
-
Eli Lilly and Company
-
John Michael Morin
-
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
-
-